Current Status
Not Enrolled
Price
Free
Get Started

Lectures

Questions and answers

19 November 2020

KEY LEARNINGS FROM AUSTRALIA’S HPV VACCINATION EXPERIENCE

Dr Julia Brotherton

Medical Director, Population Health

VCS Foundation, Melbourne, Australia

Australia is in its 14th year of HPV vaccination, which started with a catch-up programme. Before 2018, the programme used three-dose quadrivalent HPV vaccine, with male vaccination commencing in 2013. Since 2018, the routine school-based programme has used two-dose nonavalent vaccine. This presentation assesses whether Australia’s coverage, and programme impacts so far, are consistent with achieving elimination of cervical cancer in Australia.

KEY TRENDS IN HPV VACCINATION FROM A GLOBAL PERSPECTIVE

Mr Paul Bloem

HPV Vaccine Strategy Lead

World Health Organization, Geneva, Switzerland

How have other countries followed Australia’s example, and what has been learned about HPV vaccination in lower-resource settings? An overview of introduction status by region and income levels points to both challenges and successes, followed by an assessment of the key drivers affecting introductions in the coming years. Against the goal of eliminating cervical cancer, Paul assesses the feasibility of reaching global cervical cancer elimination targets, and discusses possible future innovations in HPV vaccination programmes.

CHAIR

Dr Gary Clifford

Head of the Infections and Cancer Epidemiology Group​

International Agency for Research on Cancer, Lyon, France

About Dr Gary Clifford

CONTENT

Not available

HPV Vaccination – Watch the webinar

See more...


Scroll to Top